newsfilter
← Latest News
GlobeNewswire·

Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer

NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel